 |
alanyl-glutamine dipeptide |
|---|---|
| Trade Name | Pd-Protectm |
| Orphan Indication | Prevention of complications associated with peritoneal dialysis (PD) treatment in end stage renal disease (ESRD) |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-06 00:00:00 |
| Sponsor | Zytoprotec GmbH;28/2 Mariannengasse;Vienna |
